Biotech Archives - Page 726 of 733

3 minute read

Abbott Receives FDA’s Breakthrough Device Designation To Explore Use Of Deep Brain Stimulation To Manage Severe Depression

July 12, 9:09 AM

Breakthrough Device Designations are given by the U.S. FDA to expedite the review of technologies that can improve the lives of people with life-threatening or debilitating conditions Each year, 2.8 million Americans

ABT

2 minute read

Synlogic Initiates Phase 1 Study of SYNB1353 for the Treatment of Homocystinuria

By Bill Haddad

July 12, 7:08 AM

Expected data in H2 2022 brings Synlogic to three clinical readouts this year Third candidate in less than two years to enter the clinic; Reflects productivity of Synthetic Biotic platform CAMBRIDGE, Mass., July

SYBX

3 minute read

Verve Therapeutics Doses First Human With An Investigational In Vivo Base Editing Medicine, VERVE-101, As A Potential Treatment For Heterozygous Familial Hypercholesterolemia

By Bill Haddad

July 12, 6:32 AM

Phase 1b Clinical Trial, heart-1, Now Underway and Enrolling Patients with Heterozygous Familial Hypercholesterolemia in New Zealand Company Executing VERVE-101 Global Regulatory Strategy with Potential

VERV

1 minute read

Iterum Therapeutics Shares Are Surging – Read Why

By Vandana Singh

July 11, 2:31 PM

Iterum Therapeutics plc (NASDAQ:ITRM) has agreed with the FDA under the special protocol assessment (SPA) process on the design, endpoints, and…

ITRM

1 minute read

Needham Previews Neurocrine’s Upcoming Mid-Stage Data from Essential Tremor Study

By Vandana Singh

July 11, 2:20 PM

Needham previews the upcoming Phase 2 data readout for Neurocrine Biosciences Inc's (NASDAQ: NBIX) NBI-827104, a t-type calcium channel blocker in essential tremor (ET), by mid-2022.

JAZZ

1 minute read

Why NuCana Shares Are Rising Today?

By Vandana Singh

July 11, 1:36 PM

Regional Court of Dusseldorf has ruled in favor of NuCana plc (NASDAQ:NCNA), stating that Gilead Sciences Ireland UC and Gilead Sciences GmbH…

GILD

1 minute read

Molecular Diagnostics To Be Granted US Patent titled ‘METHODS FOR SUBTYPING DIFFUSE LARGE B-CELL LYMPHOMA (AND USING THE RESULTS FOR DIAGNOSIS, PROGNOSIS, AND THERAPY SELECTION)’

By Bill Haddad

July 11, 1:29 PM

https://twitter.com/PatentGrants/status/1546546503556014080

HTGM

1 minute read

With New Phase 3 Data From Its Hemophilia Study, Novo Nordisk Plots Route To FDA

By Vandana Singh

July 11, 1:24 PM

Novo Nordisk A/S (NYSE:NVO) announced the phase 3 results of the explorer7 study, assessing the efficacy and safety of prophylactic treatment…

NVO

1 minute read

Novo Nordisk’s Mim8 Shows Potential As Once Monthly Treatment For Hemophilia A

By Vandana Singh

July 11, 12:52 PM

Novo Nordisk A/S (NYSE:NVO) announced that the phase 1 & 2 FRONTIER1 dose-escalation study in treating people with hemophilia…

NVO

1 minute read

Aethlon Medical Secures FDA Clearance For Amendment In Initial-Stage COVID-19 Study

By Ragothaman Srinivasan

July 11, 11:41 AM

The U.S. Food and Drug Administration (FDA) has approved an amendment to the protocol of the ongoing clinical trial investigating Aethlon Medical’s (NASDAQ: AEMD) lead therapy Aethlon Hemopurifier for patients with severe COVID-19.

AEMD